The vaginal tissues are rich in estrogen receptors. In healthy reproductive years, estrogen maintains a thick, elastic, well-lubricated epithelium supported by a dense collagen and elastin network. During perimenopause and menopause, circulating estrogen can drop by more than 90 percent, triggering epithelial thinning, reduced blood flow, and diminished natural secretions. The Menopause Society recognizes this process as genitourinary syndrome of menopause, affecting an estimated 50 to 70 percent of postmenopausal women.
This estrogen shift cascades into visible and felt changes: the vaginal canal shortens and narrows, pH rises and shifts the microbiome, and the supportive collagen scaffolding loses density. Patients often notice this as burning during intercourse, an unfamiliar tightness paired with dryness, or paradoxically a feeling of looseness because surrounding muscle tone has weakened. Addressing the underlying hormone environment through Hormone Replacement Therapy often complements tissue-targeted treatment.
Childbirth, hysterectomy, and certain cancer treatments compound the picture by stretching or devascularizing tissue. The result is a two-part concern: dryness from reduced hydration and lubrication, and laxity from collagen and muscular changes in the vaginal wall and pelvic floor.
